Grifols will build new manufacturing site in Spain to double its plasma fractionation capacity in Europe
Grifols discloses transfers of value made to European healthcare professionals and healthcare organizations in 2024
Grifols’ positive fibrinogen phase 3 trial results published in The Lancet’s eClinicalMedicine
Access all the information about Grifols’ 2025 Annual General Meeting.
Our media relations team can be reached at:
(+34) 93 571 00 02
media@grifols.com.
Restricted to media inquiries only.
For general questions and requests, please contact corporatecomms@grifols.com.
Follow us on social media.
Seeking early biological signs of disease.
Newsroom
Access our latest press releases.
Media Center
Downloadable resources for media professionals.